ArticleCureus2024
Risk of Pleural Recurrence in Early-Stage Non-small Cell Lung Cancer in Patients Treated With Surgery vs Stereotactic Ablative Radiotherapy.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPleural recurrence has been reported after thoracic surgery and radiation treatment, and reports show that the surgery as the first treatment may be associated with an increased incidence of pleural recurrence. The main objective of this study was to compare the incidence of ipsilateral pleural recurrence in patients with non-small cell lung cancer (NSCLC) who underwent surgical resection or curative-intent radiotherapy.
methodsWe performed a retrospective cohort study of patients aged 18 or older with stage I NSCLC who underwent surgical resection or curative-intent radiotherapy at our institution. The primary outcome of interest was an incidence of ipsilateral pleural recurrence at the time of first cancer recurrence. Secondary outcomes were the time of any first recurrence type of biopsy approach and the incidence of pleural recurrence.
resultsOur cohort included 512 patients for whom complete data were available. Of these, 50 (9.7%) patients experienced recurrence and 51 died during the five-year follow-up since their first treatment. There was no difference in the incidence of ipsilateral pleural recurrence (P=0.348), the incidence of any recurrence (P=0.069), or time to first recurrence (P=0.088) between the curative intent surgery and radiotherapy groups. Biopsy type was not associated with recurrence.
conclusionThere was no difference in the incidence of ipsilateral pleural recurrence between the curative intent surgery and radiotherapy groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.